Aridis Pharmaceuticals In... (ARDS)
OTC: ARDS
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 01, 2025, 9:51 AM
Aridis Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -11.51 | 0.16 | -0.35 | -0.84 | -0.45 | -0.59 | -0.96 | -0.83 | -0.55 | -3.79 | -2.19 |
PEG Ratio | 0.11 | -0.00 | 0.01 | 0.03 | -0.04 | n/a | 0.03 | 0.01 | -0.00 | 0.14 | -0.16 |
PS Ratio | 9.16 | 0.40 | n/a | n/a | n/a | 66.68 | n/a | 59.27 | 467.66 | 2.52K | n/a |
PB Ratio | -0.32 | -0.53 | -0.34 | -0.89 | -0.46 | -0.7 | -1.53 | -2.39 | -11.03 | -6.16 | -7.06 |
P/FCF Ratio | -3.89 | -1.83 | -2.39 | -2.5 | -3.86 | -3.17 | -3.06 | -9.17 | -5.26 | -12.35 | -13.9 |
P/OCF Ratio | -3.89 | -1.83 | -2.39 | -2.52 | -3.86 | -3.17 | -3.06 | -9.06 | -5.33 | -12.58 | -15.06 |
OCF/S Ratio | -2.36 | -0.22 | n/a | n/a | n/a | -21.02 | n/a | -6.54 | -87.68 | -200.21 | n/a |
Debt / Equity Ratio | -0.41 | -0.42 | -0.14 | -0.25 | -0.39 | -0.47 | -0.64 | -0.42 | n/a | n/a | -0.08 |
Quick Ratio | 0.24 | 0.19 | 0.19 | 0.32 | 0.20 | 0.41 | 0.64 | 0.81 | 0.82 | 0.38 | 0.61 |
Current Ratio | 0.24 | 0.19 | 0.19 | 0.32 | 0.20 | 0.41 | 0.64 | 0.80 | 0.82 | 0.38 | 0.61 |
Asset Turnover | 0.06 | 3.03 | n/a | n/a | n/a | 0.02 | n/a | 0.02 | 0.00 | 0.00 | n/a |
Interest Coverage | n/a | 4.56K | n/a | n/a | n/a | -967.13 | -21.71 | -40.69 | n/a | n/a | n/a |
Return on Equity | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.12 | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.4 | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | 1.00 | n/a | n/a | n/a | 1.00 | n/a | 1.00 | 1.00 | 1.00 | n/a |
Net Profit Margin | -0.2 | 0.62 | n/a | n/a | n/a | -28.15 | n/a | -17.94 | -214.31 | -166.36 | n/a |
Pretax Profit Margin | -0.2 | 0.62 | n/a | n/a | n/a | -27.33 | n/a | -17.94 | -214.31 | -166.36 | n/a |
Operating Profit Margin | -2.08 | 0.70 | n/a | n/a | n/a | -26.5 | n/a | -17.49 | -214.55 | -188.91 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -1.94 | 0.70 | n/a | n/a | n/a | -26.05 | n/a | -15.49 | -213.59 | -186.09 | n/a |